17beta-estradiol induces both up-regulation and processing of cyclin E in a calpain-dependent manner in MCF-7 breast cancer cells

FEBS Letters

Volumn 586, Issue 6, 2012, Pages 892-896

  Hou, Jianmei ^a   Wang, Xudong ^a   Li, Yang ^a   Liu, Xiaohong ^a   Wang, Zhuting ^a   An, Jing ^a   Yang, Li ^a   He, Yan ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

17beta estradiol; Breast cancer cell; Calpain; Cyclin E; Proteolysis; Up regulation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALCOHOL; CALCIUM; CALPAIN; CALPASTATIN; CALPEPTIN; CYCLIN E; ESTRADIOL; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION;

BREAST NEOPLASMS; BUTADIENES; CALCIUM; CALPAIN; CELL LINE, TUMOR; CHELATING AGENTS; CYCLIN E; EGTAZIC ACID; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; NITRILES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84862783308     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.02.018     Document Type: Article

References (21)

1. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Morgan, D.O., Franza, BR. and Roberts, J.M (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694.
2. Keyomarsi, K., Conte Jr., D., Toyofuku, W. and Fox, M.P. (1995) Deregulation of cyclin E in breast cancer. Oncogene 11, 941-950.
3. Wingate, H., Puskas, A., Duong, M., Bui, T., Richardson, D., Liu, Y., Tucker, S.L., Van Pelt, C., Meijer, L., Hunt, K. and Keyomarsi, K. (2009) Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 8, 1062-1068.
4. Akli, S., Van Pelt, C.S., Bui, T., Multani, A.S., Chang, S., Johnson, D., Tucker, S. and Keyomarsi, K. (2007) Over-expression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res. 67, 7212-7222. (Pubitemid 47206549)
5. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y., Hortobagyi, G.N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T.W. and Bacus, S.S. (2002) Cyclin E and survival in patients with breast cancer. N. Engl. J. Med. 347, 1566-1575. (Pubitemid 35315837)
6. Corin, I., Larsson, L., Bergström, J., Gustavsson, B. and Derwinger, K. (2010) A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer. Acta Oncol. 49, 63-69.
7. Milne, A.N., Carvalho, R., Jansen, M., Kranenbarg, E.K., van de Velde, C.J. and Morsink, F.M. (2008) Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival. J. Clin. Pathol. 61 (3), 311-316. (Pubitemid 351354236)
8. Davidson, B., Skrede, M., Silins, I., Shih, IeM., Trope, C.G. and Flørenes, V.A. (2007) Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Cancer 110, 1264-1271. (Pubitemid 47435597)
9. Akli, S., Bui, T., Wingate, H., Biernacka, A., Moulder, S., Tucker, S.L., Hunt, K.K. and Keyomarsi, K. (2010) Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin. Cancer Res. 16, 1179-1190.
10. Wang, X.D., Rosales, J.L., Magliocco, A., Gnanakumar, R. and Lee, K.Y. (2003) Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 22, 769-774. (Pubitemid 36269291)
11. Libertini, S.J., Robinson, B.S., Dhillon, N.K., Glick, D., George, M., Dandekar, S., Gregg, J.P., Sawai, E. and Mudryj, M. (2005) Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res. 65, 10700-10708. (Pubitemid 41713337)
12. Porter, D.C., Zhang, N., Danes, C., McGahren, M.J., Harwell, R.M., Faruki, S. and Keyomarsi, K. (2001) Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol. Cell. Biol. 21, 6254-6269. (Pubitemid 34263525)
13. Nguyen, H.H., Aronchik, I., Brar, G.A., Nguyen, D.H., Bjeldanes, L.F. and Firestone, G.L. (2008) The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing. Proc. Natl. Acad. Sci. USA 105, 19750-19755.
14. Glading, A., Chang, P., Lauffenburger, D.A. and Wells, A. (2000) Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J. Biol. Chem. 275, 2390-2398. (Pubitemid 30081997)
15. Baki, A., Tompa, P., Alexa, A., Molnár, O. and Friedrich, P. (1996) Autolysis parallels activation of mu-calpain. Biochem. J. 318, 897-901.
16. Fan, S., Meng, Q., Gao, B., Grossman, J., Yadegari, M., Goldberg, I.D. and Rosen, E.M. (2000) Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res. 60, 5635-5639.
17. Zhang, L., Li, X., Zhao, L., Zhang, L., Zhang, G., Wang, J. and Wei, L. (2009) Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells. J. Cell. Biochem. 106, 553-562.
18. Improta-Brears, T., Whorton, A.R., Codazzi, F., York, J.D., Meyer, T. and McDonnell, D.P. (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 96, 4686-4691. (Pubitemid 29190397)
19. Storr, S.J., Woolston, C.M., Barros, F.F., Green, A.R., Shehata, M., Chan, S.Y., Ellis, I.O. and Martin, S.G. (2011) Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy. Int. J. Cancer 129, 1773-1780.
20. Liang, Y., Gao, H., Lin, S.Y., Goss, J.A., Brunicardi, F.C. and Li, K. (2010) siRNA-based targeting of cyclin E over-expression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS ONE 5, e12860.
21. Chakravarty, D., Nair, S.S., Santhamma, B., Nair, B.C., Wang, L., Bandyopadhyay, A., Agyin, J.K., Brann, D., Sun, L.Z., Yeh, I.T., Lee, F.Y., Tekmal, R.R., Kumar, R. and Vadlamudi, R.K. (2010) Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Cancer Res. 70 (1), 4092-4101.